In resource‐limited areas, such as sub‐Saharan Africa, problems in accurate cancer case
ascertainment and enumeration of the at‐risk population make it difficult to estimate cancer …

Background: HIV-associated Kaposi sarcoma (KS) is one of the most common malignancies
in sub-Saharan Africa. The diagnosis is often based on clinical suspicion, without …

Background The most effective treatment for advanced AIDS-associated Kaposi sarcoma is
paclitaxel or pegylated liposomal doxorubicin (PLD); neither is routinely used in sub-…

The World Health Organization (WHO) refers to cervical cancer as a public health problem,
and sub‐Saharan Africa bears the world's highest incidence. In the realm of screening, …

Background: Although many patients with Kaposi sarcoma (KS) in sub-Saharan Africa are
diagnosed with AIDS Clinical Trials Group (ACTG) T1 disease, T1 staging insufficiently …

Fueled by HIV, sub-Saharan Africa has the highest incidence of Kaposi's sarcoma (KS) in the
world. Despite this, KS diagnosis in the region is based mostly on clinical grounds. Where …

Introduction The experience of stigma can be multifaceted for people with HIV and cancer.
Kaposi's sarcoma (KS), one of the most common HIV‐associated cancers in sub‐Saharan …

Patients with monitoring LFT abnormalities that resolved after completion of therapy 17 (1.8)
Patients with monitoring LFT abnormalities that resolved upon premature discontinuation of …

Background: Although HIV-associated Kaposi sarcoma (KS) is frequently diagnosed at an
advanced stage in sub-Saharan Africa, reasons for diagnostic delays have not been well …

Background: Other than Kaposi sarcoma (KS)–associated herpesvirus and CD4+ T-cell
lymphopenia, the mechanisms responsible for KS in the context of HIV are poorly understood. …